Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Kathleen Moore, MD, MS - Targeting Disease Progression in Advanced Ovarian Cancer: Can Combination PARP Inhibitors and Immune Checkpoint Inhibitors Improve Outcomes?

    Kathleen Moore, MD, MS - Targeting Disease Progression in Advanced Ovarian Cancer: Can Combination PARP Inhibitors and Immune Checkpoint Inhibitors Im…

    FromCME in Minutes: Education in Oncology & Hematology

    Start listeningView podcast show

    Kathleen Moore, MD, MS - Targeting Disease Progression in Advanced Ovarian Cancer: Can Combination PARP Inhibitors and Immune Checkpoint Inhibitors Im…

    FromCME in Minutes: Education in Oncology & Hematology

    ratings:
    Length:
    14 minutes
    Released:
    Aug 31, 2022
    Format:
    Podcast episode

    Description

    Please visit answersincme.com/AXF860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in gynecologic cancers discusses the potential role of combination poly (ADP-ribose) polymerase (PARP) inhibitors and immune checkpoint inhibitors (ICIs) in improving outcomes in advanced ovarian cancer.Upon completion of this activity, participants should be better able to: Discuss the clinical rationale for combining PARP inhibitors with ICIs; Review the clinical profile of PARP inhibitors in combination with ICIs for patients with advanced ovarian cancer; and Identify the potential place in therapy for PARP inhibitors in combination with ICIs in advanced ovarian cancer.
    Released:
    Aug 31, 2022
    Format:
    Podcast episode

    Titles in the series (84)

    Get answers in 25 minutes or less from world-class experts and earn CME/CE credit with CME in Minutes: Education in Oncology & Hematology by Answers in CME. Benefit from digests of latest advancements, thoughtful case studies, and nuanced perspectives anytime, anywhere, and on any device. Inspiring and engaging programs designed for oncologists and hematologists to cover the diagnosis, staging, treatment, follow-up, and clinical management of tumors and hematological malignancies. Earning your CME/CE credits has never been faster or easier. Visit the URL for each individual program to request continuing education credit or access the slides.